HEADER HYDROLASE 04-JUN-25 9RF2 TITLE M. TUBERCULOSIS MEETS EUROPEAN LEAD FACTORY: IDENTIFICATION AND TITLE 2 STRUCTURAL CHARACTERIZATION OF NOVEL RV0183 INHIBITORS USING X-RAY TITLE 3 CRYSTALLOGRAPHY: ELF5 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MONOACYLGLYCEROL LIPASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MGL; COMPND 5 EC: 3.1.1.23; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS H37RV; SOURCE 3 ORGANISM_TAXID: 83332; SOURCE 4 GENE: RV0183; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS RV0183, INHIBITOR, MONOACYLGLYCEROL LIPASE, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR L.RIEGLER-BERKET,L.GOEDL,M.OBERER,N.POLIDORI REVDAT 2 29-OCT-25 9RF2 1 JRNL REVDAT 1 13-AUG-25 9RF2 0 JRNL AUTH L.RIEGLER-BERKET,L.GODL,N.POLIDORI,P.ASCHAUER,C.GRININGER, JRNL AUTH 2 G.PROSSER,J.LICHTENEGGER,T.SAGMEISTER,L.PARIGGER,C.C.GRUBER, JRNL AUTH 3 N.REILING,M.OBERER JRNL TITL M. TUBERCULOSIS MEETS EUROPEAN LEAD FACTORY:IDENTIFICATION JRNL TITL 2 AND STRUCTURAL CHARACTERIZATION OF NOVEL RV0183 INHIBITORS JRNL TITL 3 USING X-RAY CRYSTALLOGRAPHY JRNL REF DISEASE AND THERAPEUTICS V. 1 00002 2025 JRNL DOI 10.1016/J.DIST.2025.100002 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.20.1_4487: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.39 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 40788 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.190 REMARK 3 FREE R VALUE : 0.203 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.880 REMARK 3 FREE R VALUE TEST SET COUNT : 1989 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 41.3900 - 3.8600 0.99 2978 154 0.1914 0.1706 REMARK 3 2 3.8600 - 3.0600 1.00 2825 153 0.1720 0.1888 REMARK 3 3 3.0600 - 2.6700 1.00 2802 136 0.1902 0.2167 REMARK 3 4 2.6700 - 2.4300 1.00 2772 171 0.1767 0.2056 REMARK 3 5 2.4300 - 2.2600 1.00 2776 140 0.1783 0.2185 REMARK 3 6 2.2600 - 2.1200 1.00 2769 123 0.1772 0.2135 REMARK 3 7 2.1200 - 2.0200 1.00 2761 138 0.1781 0.2270 REMARK 3 8 2.0200 - 1.9300 1.00 2743 150 0.1850 0.1959 REMARK 3 9 1.9300 - 1.8500 1.00 2781 141 0.2036 0.2394 REMARK 3 10 1.8500 - 1.7900 1.00 2772 141 0.2157 0.2642 REMARK 3 11 1.7900 - 1.7300 1.00 2720 142 0.2377 0.2422 REMARK 3 12 1.7300 - 1.6800 1.00 2716 141 0.2443 0.2854 REMARK 3 13 1.6800 - 1.6400 0.99 2758 129 0.2712 0.3003 REMARK 3 14 1.6400 - 1.6000 0.96 2627 130 0.3200 0.3457 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.191 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.794 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 30.94 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.84 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 2335 REMARK 3 ANGLE : 0.858 3204 REMARK 3 CHIRALITY : 0.057 359 REMARK 3 PLANARITY : 0.009 425 REMARK 3 DIHEDRAL : 12.909 907 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 9RF2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-JUN-25. REMARK 100 THE DEPOSITION ID IS D_1292148152. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-NOV-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PETRA III, DESY REMARK 200 BEAMLINE : P11 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.033230 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40806 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 41.390 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.5400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.66 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.49 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.26 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 1000, PEG 3350, MPD, HEPES, MOPS, REMARK 280 CHAPS, CHAPSO, SODIUM GLYCOCHOLATE HYDRATE, TAUROCHOLIC ACID REMARK 280 SODIUM SALT HYDRATE, PH 7.5, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 2 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 X,-Y,-Z REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 -X,-Y+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 41.39200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 45.35200 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 41.39200 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 45.35200 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 130 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10670 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -27 REMARK 465 SER A -26 REMARK 465 TYR A -25 REMARK 465 TYR A -24 REMARK 465 HIS A -23 REMARK 465 HIS A -22 REMARK 465 HIS A -21 REMARK 465 HIS A -20 REMARK 465 HIS A -19 REMARK 465 HIS A -18 REMARK 465 ASP A -17 REMARK 465 TYR A -16 REMARK 465 ASP A -15 REMARK 465 ILE A -14 REMARK 465 PRO A -13 REMARK 465 THR A -12 REMARK 465 THR A -11 REMARK 465 GLU A -10 REMARK 465 ASN A -9 REMARK 465 LEU A -8 REMARK 465 TYR A -7 REMARK 465 PHE A -6 REMARK 465 GLN A -5 REMARK 465 GLY A -4 REMARK 465 ALA A -3 REMARK 465 MET A -2 REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 MET A 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O PRO A 124 O HOH A 401 2.17 REMARK 500 NH1 ARG A 52 OD1 ASP A 269 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 26 40.27 -89.15 REMARK 500 ASP A 26 41.88 -89.15 REMARK 500 GLU A 41 -150.69 -103.51 REMARK 500 SER A 110 -122.10 62.50 REMARK 500 ALA A 134 59.70 37.07 REMARK 500 ALA A 138 47.84 -140.84 REMARK 500 REMARK 500 REMARK: NULL DBREF 9RF2 A 1 279 UNP O07427 MGLL_MYCTU 1 279 SEQADV 9RF2 MET A -27 UNP O07427 INITIATING METHIONINE SEQADV 9RF2 SER A -26 UNP O07427 EXPRESSION TAG SEQADV 9RF2 TYR A -25 UNP O07427 EXPRESSION TAG SEQADV 9RF2 TYR A -24 UNP O07427 EXPRESSION TAG SEQADV 9RF2 HIS A -23 UNP O07427 EXPRESSION TAG SEQADV 9RF2 HIS A -22 UNP O07427 EXPRESSION TAG SEQADV 9RF2 HIS A -21 UNP O07427 EXPRESSION TAG SEQADV 9RF2 HIS A -20 UNP O07427 EXPRESSION TAG SEQADV 9RF2 HIS A -19 UNP O07427 EXPRESSION TAG SEQADV 9RF2 HIS A -18 UNP O07427 EXPRESSION TAG SEQADV 9RF2 ASP A -17 UNP O07427 EXPRESSION TAG SEQADV 9RF2 TYR A -16 UNP O07427 EXPRESSION TAG SEQADV 9RF2 ASP A -15 UNP O07427 EXPRESSION TAG SEQADV 9RF2 ILE A -14 UNP O07427 EXPRESSION TAG SEQADV 9RF2 PRO A -13 UNP O07427 EXPRESSION TAG SEQADV 9RF2 THR A -12 UNP O07427 EXPRESSION TAG SEQADV 9RF2 THR A -11 UNP O07427 EXPRESSION TAG SEQADV 9RF2 GLU A -10 UNP O07427 EXPRESSION TAG SEQADV 9RF2 ASN A -9 UNP O07427 EXPRESSION TAG SEQADV 9RF2 LEU A -8 UNP O07427 EXPRESSION TAG SEQADV 9RF2 TYR A -7 UNP O07427 EXPRESSION TAG SEQADV 9RF2 PHE A -6 UNP O07427 EXPRESSION TAG SEQADV 9RF2 GLN A -5 UNP O07427 EXPRESSION TAG SEQADV 9RF2 GLY A -4 UNP O07427 EXPRESSION TAG SEQADV 9RF2 ALA A -3 UNP O07427 EXPRESSION TAG SEQADV 9RF2 MET A -2 UNP O07427 EXPRESSION TAG SEQADV 9RF2 GLY A -1 UNP O07427 EXPRESSION TAG SEQADV 9RF2 SER A 0 UNP O07427 EXPRESSION TAG SEQADV 9RF2 ALA A 74 UNP O07427 LYS 74 ENGINEERED MUTATION SEQRES 1 A 307 MET SER TYR TYR HIS HIS HIS HIS HIS HIS ASP TYR ASP SEQRES 2 A 307 ILE PRO THR THR GLU ASN LEU TYR PHE GLN GLY ALA MET SEQRES 3 A 307 GLY SER MET THR THR THR ARG THR GLU ARG ASN PHE ALA SEQRES 4 A 307 GLY ILE GLY ASP VAL ARG ILE VAL TYR ASP VAL TRP THR SEQRES 5 A 307 PRO ASP THR ALA PRO GLN ALA VAL VAL VAL LEU ALA HIS SEQRES 6 A 307 GLY LEU GLY GLU HIS ALA ARG ARG TYR ASP HIS VAL ALA SEQRES 7 A 307 GLN ARG LEU GLY ALA ALA GLY LEU VAL THR TYR ALA LEU SEQRES 8 A 307 ASP HIS ARG GLY HIS GLY ARG SER GLY GLY ALA ARG VAL SEQRES 9 A 307 LEU VAL ARG ASP ILE SER GLU TYR THR ALA ASP PHE ASP SEQRES 10 A 307 THR LEU VAL GLY ILE ALA THR ARG GLU TYR PRO GLY CYS SEQRES 11 A 307 LYS ARG ILE VAL LEU GLY HIS SER MET GLY GLY GLY ILE SEQRES 12 A 307 VAL PHE ALA TYR GLY VAL GLU ARG PRO ASP ASN TYR ASP SEQRES 13 A 307 LEU MET VAL LEU SER ALA PRO ALA VAL ALA ALA GLN ASP SEQRES 14 A 307 LEU VAL SER PRO VAL VAL ALA VAL ALA ALA LYS LEU LEU SEQRES 15 A 307 GLY VAL VAL VAL PRO GLY LEU PRO VAL GLN GLU LEU ASP SEQRES 16 A 307 PHE THR ALA ILE SER ARG ASP PRO GLU VAL VAL GLN ALA SEQRES 17 A 307 TYR ASN THR ASP PRO LEU VAL HIS HIS GLY ARG VAL PRO SEQRES 18 A 307 ALA GLY ILE GLY ARG ALA LEU LEU GLN VAL GLY GLU THR SEQRES 19 A 307 MET PRO ARG ARG ALA PRO ALA LEU THR ALA PRO LEU LEU SEQRES 20 A 307 VAL LEU HIS GLY THR ASP ASP ARG LEU ILE PRO ILE GLU SEQRES 21 A 307 GLY SER ARG ARG LEU VAL GLU CYS VAL GLY SER ALA ASP SEQRES 22 A 307 VAL GLN LEU LYS GLU TYR PRO GLY LEU TYR HIS GLU VAL SEQRES 23 A 307 PHE ASN GLU PRO GLU ARG ASN GLN VAL LEU ASP ASP VAL SEQRES 24 A 307 VAL ALA TRP LEU THR GLU ARG LEU HET 8KE A 301 28 HET I3F A 302 56 HET CL A 303 1 HETNAM 8KE [1-[6-[(4-METHOXYPHENYL)AMINO]PYRIMIDIN-4-YL]PYRAZOL-4- HETNAM 2 8KE YL]-[(3S)-3-OXIDANYLPYRROLIDIN-1-YL]METHANONE HETNAM I3F [1-[6-[(4-METHOXYPHENYL)AMINO]PYRIMIDIN-4-YL]PYRAZOL-4- HETNAM 2 I3F YL]-[(3R)-3-OXIDANYLPYRROLIDIN-1-YL]METHANONE HETNAM CL CHLORIDE ION FORMUL 2 8KE C19 H20 N6 O3 FORMUL 3 I3F C19 H20 N6 O3 FORMUL 4 CL CL 1- FORMUL 5 HOH *62(H2 O) HELIX 1 AA1 ILE A 13 ASP A 15 5 3 HELIX 2 AA2 HIS A 42 ARG A 45 5 4 HELIX 3 AA3 TYR A 46 ALA A 56 1 11 HELIX 4 AA4 ASP A 80 TYR A 99 1 20 HELIX 5 AA5 SER A 110 ARG A 123 1 14 HELIX 6 AA6 ALA A 138 LEU A 142 5 5 HELIX 7 AA7 SER A 144 GLY A 155 1 12 HELIX 8 AA8 ASP A 167 ILE A 171 5 5 HELIX 9 AA9 ASP A 174 THR A 183 1 10 HELIX 10 AB1 ALA A 194 ALA A 211 1 18 HELIX 11 AB2 PRO A 212 LEU A 214 5 3 HELIX 12 AB3 ILE A 231 VAL A 241 1 11 HELIX 13 AB4 GLU A 257 GLU A 261 5 5 HELIX 14 AB5 GLU A 263 LEU A 279 1 17 SHEET 1 AA1 8 THR A 3 ALA A 11 0 SHEET 2 AA1 8 ARG A 17 PRO A 25 -1 O ILE A 18 N PHE A 10 SHEET 3 AA1 8 LEU A 58 LEU A 63 -1 O ALA A 62 N ASP A 21 SHEET 4 AA1 8 ALA A 31 ALA A 36 1 N VAL A 33 O VAL A 59 SHEET 5 AA1 8 LYS A 103 HIS A 109 1 O ILE A 105 N VAL A 32 SHEET 6 AA1 8 LEU A 129 SER A 133 1 O SER A 133 N GLY A 108 SHEET 7 AA1 8 LEU A 218 GLY A 223 1 O LEU A 219 N LEU A 132 SHEET 8 AA1 8 VAL A 246 TYR A 251 1 O LYS A 249 N VAL A 220 SHEET 1 AA2 2 PRO A 162 GLN A 164 0 SHEET 2 AA2 2 VAL A 192 PRO A 193 -1 O VAL A 192 N GLN A 164 CRYST1 40.411 82.784 90.704 90.00 90.00 90.00 P 2 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024746 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012080 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011025 0.00000 CONECT 2191 2192 2201 CONECT 2192 2191 2193 2218 CONECT 2193 2192 2215 CONECT 2194 2195 2205 CONECT 2195 2194 2202 CONECT 2196 2216 CONECT 2197 2198 2213 CONECT 2198 2197 2199 2200 CONECT 2199 2198 2214 CONECT 2200 2198 2215 2217 CONECT 2201 2191 2215 CONECT 2202 2195 2203 2216 CONECT 2203 2202 2204 CONECT 2204 2203 2205 CONECT 2205 2194 2204 2210 CONECT 2206 2207 2210 2212 CONECT 2207 2206 2208 CONECT 2208 2207 2211 2213 CONECT 2209 2211 2212 CONECT 2210 2205 2206 CONECT 2211 2208 2209 CONECT 2212 2206 2209 CONECT 2213 2197 2208 2214 CONECT 2214 2199 2213 CONECT 2215 2193 2200 2201 CONECT 2216 2196 2202 CONECT 2217 2200 CONECT 2218 2192 CONECT 2219 2221 2239 CONECT 2220 2222 2240 CONECT 2221 2219 2223 2273 CONECT 2222 2220 2224 2274 CONECT 2223 2221 2267 CONECT 2224 2222 2268 CONECT 2225 2227 2247 CONECT 2226 2228 2248 CONECT 2227 2225 2241 CONECT 2228 2226 2242 CONECT 2229 2269 CONECT 2230 2270 CONECT 2231 2233 2263 CONECT 2232 2234 2264 CONECT 2233 2231 2235 2237 CONECT 2234 2232 2236 2238 CONECT 2235 2233 2265 CONECT 2236 2234 2266 CONECT 2237 2233 2267 2271 CONECT 2238 2234 2268 2272 CONECT 2239 2219 2267 CONECT 2240 2220 2268 CONECT 2241 2227 2243 2269 CONECT 2242 2228 2244 2270 CONECT 2243 2241 2245 CONECT 2244 2242 2246 CONECT 2245 2243 2247 CONECT 2246 2244 2248 CONECT 2247 2225 2245 2257 CONECT 2248 2226 2246 2258 CONECT 2249 2251 2257 2261 CONECT 2250 2252 2258 2262 CONECT 2251 2249 2253 CONECT 2252 2250 2254 CONECT 2253 2251 2259 2263 CONECT 2254 2252 2260 2264 CONECT 2255 2259 2261 CONECT 2256 2260 2262 CONECT 2257 2247 2249 CONECT 2258 2248 2250 CONECT 2259 2253 2255 CONECT 2260 2254 2256 CONECT 2261 2249 2255 CONECT 2262 2250 2256 CONECT 2263 2231 2253 2265 CONECT 2264 2232 2254 2266 CONECT 2265 2235 2263 CONECT 2266 2236 2264 CONECT 2267 2223 2237 2239 CONECT 2268 2224 2238 2240 CONECT 2269 2229 2241 CONECT 2270 2230 2242 CONECT 2271 2237 CONECT 2272 2238 CONECT 2273 2221 CONECT 2274 2222 MASTER 277 0 3 14 10 0 0 6 2241 1 84 24 END